SCHEDULE 13D/A//SEC Filing
LAVA Therapeutics NV SCHEDULE 13D/A
Accession 0001193125-25-207693
CIK 0001687880other
Filed
Sep 17, 8:00 PM ET
Accepted
Sep 18, 7:08 PM ET
Size
19.2 KB
Accession
0001193125-25-207693
Documents
Issuer
Versant Venture Capital VI, L.P.
CIK 0001687880
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001687880
Filing Metadata
- Form type
- SCHEDULE 13D/A
- Filed
- Sep 17, 8:00 PM ET
- Accepted
- Sep 18, 7:08 PM ET
- Size
- 19.2 KB